Table 3.
Smoking Cessation* | Enhanced Usual Care Group (N=92) | Financial Incentive Group (N=90) | P Value | ||
---|---|---|---|---|---|
n/N | Percent | n/N | Percent | ||
Smoking cessation at 2 weeks (%) | |||||
Self-reported | 27/67 | 40.3 | 35/75 | 46.7 | 0.445 |
Smoking cessation at 2 months (%) | |||||
Self-reported | 24/65 | 36.9 | 40/68 | 58.8 | 0.012 |
Bioconfirmed | 12/48 | 25.0 | 14/40 | 35.0 | 0.306 |
No saliva sample submitted† | 7/24 | 29.2 | 16/40 | 40.0 | 0.382 |
Positive saliva sample submitted† | 5/24 | 20.8 | 10/40 | 25.0 | 0.703 |
Smoking cessation at 6 months (%)‡ | |||||
Self-reported | 26/70 | 37.1 | 35/64 | 54.7 | 0.042 |
Bioconfirmed | 5/56 | 8.9 | 9/46 | 19.6 | 0.103 |
No saliva sample submitted† | 5/26 | 19.2 | 8/35 | 22.9 | 0.732 |
Positive saliva sample submitted† | 16/26 | 61.5 | 18/35 | 51.4 | 0.432 |
The denominator for self-reported smoking cessation indicates the number of participants who completed follow-up at each time point. The denominator for bioconfirmation indicates the number of participants who submitted a saliva sample or provided expired CO
Among participants with self-reported smoking cessation
P value for bioconfirmed smoking cessation at 6 months based on logistic regression model with multiple imputation for missing smoking cessation values
Note: At 6 months, 72 patients in the enhanced usual care group and 65 patients in the financial incentive group participated in the phone survey. Of these patients, 2 patients in the enhanced usual care group and 1 patient in the financial incentive group did not respond to questions about current smoking. After the 6 month phone survey, 56 patients in the enhanced usual care group and 46 patients in the financial incentive group subsequently presented for bioconfirmation.